SINOVAC BIOTECH LTD Income (Loss) from Continuing Operations, Per Diluted Share
SINOVAC BIOTECH LTD (SVA) reported Income (Loss) from Continuing Operations, Per Diluted Share of $1.27 per share for the 12-month period ending 2024-12-31, per its 20-F filed 2026-04-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-04-30
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month as first filed |
|---|---|---|
| 2024-12-31 | $1.27 20-F · filed 2026-04-30 | |
| 2023-12-31 | -$0.19 20-F · filed 2026-04-30 | |
| 2022-12-31 | $0.20 20-F · filed 2026-04-30 | |
| 2021-12-31 | $113.44 20-F · filed 2026-04-30 | |
| 2018-12-31 | $0.34 20-F · filed 2019-04-29 | |
| 2017-12-31 | $0.45 20-F · filed 2019-04-29 | |
| 2016-12-31 | -$0.05 20-F · filed 2019-04-29 | |
| 2015-12-31 | -$0.02 20-F · filed 2018-05-11 | -$0.01 20-F · filed 2016-04-25 |
| 2014-12-31 | $0.00 20-F · filed 2017-11-22 | $0.01 20-F · filed 2016-04-25 |
| 2013-12-31 | $0.15 20-F · filed 2016-04-25 |